Skip to NavigationSkip to content

News

Amgen has revealed that its PCSK9 inhibitor Repatha (evolocumab) has received approval from the European Commission in a new indication: to reduce...
Ipsen has revealed that it has received approval for the use of Cabometyx for first-line use in patients with advanced renal cell carcinoma.
The FDA has made an important leap in combatting the US opioid crisis with the approval of Lucemyra (lofexidine hydrochloride) for managing the...
A new report published by the Business, Energy and Industrial Strategy Committee has called for the UK government to ensure that the pharmaceutical...
NICE has announced that Roche's Tecentriq will be made available for patients with advanced bladder cancer as a second-line treatment.
Eli Lilly has released new Phase 3 results for its CGRP inhibitor galcanezumab in the treatment of episodic cluster headache, showing that the...
The saga of Novartis’ ill-advised $1.2 million deal with US President Donald Trump’s lawyer Michael Cohen continues to unfold as it emerges that...
Pfizer’s Retacrit, a biosimilar version of Amgen’s Epogen and Janssen’s Procrit, has been approved for use in the US by the FDA, making it the...
Researchers from Imperial College London have discovered how to interfere with one of the building blocks that allows the common cold to replicate...
We are in the midst of a breath-taking series of changes in the world of pharmacovigilance, both within Europe and beyond and this has prompted new...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches